Compare Smruthi Organic with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
INR 120 Cr (Micro Cap)
23.00
32
1.43%
0.11
7.03%
1.70
Total Returns (Price + Dividend) 
Latest dividend: 1.5 per share ex-dividend date: Jun-13-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Smruthi Organics Ltd Falls to 52-Week Low of Rs 102 as Sell-Off Deepens
For the second consecutive session, Smruthi Organics Ltd has seen its share price decline, hitting a fresh 52-week low of Rs 102 on 30 Mar 2026. This latest drop extends the stock’s recent underperformance despite some positive financial indicators.
Read full news article
Smruthi Organics Ltd is Rated Sell
Smruthi Organics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Smruthi Organics Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals
Smruthi Organics Ltd has seen its investment rating downgraded from Hold to Sell as of 6 March 2026, reflecting a shift in technical indicators and concerns over its long-term financial growth. Despite some positive quarterly results and attractive valuation metrics, the company’s overall performance and technical trends have prompted a cautious stance among investors.
Read full news article Announcements 
Intimation Under Regulation 30 Of SEBI (LODR) Regulations - Receipt Of CEP Certificate From EDQM
09-Mar-2026 | Source : BSEWe are pleased to inform that the Company has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & Helathcare (EDQM) Europe for its product Amlodipine Besilate.
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Receipt Of Attestation Of Inspection From EDQM
04-Mar-2026 | Source : BSEReceipt of Attestation of Inspection from EDQM
Announcement under Regulation 30 (LODR)-Newspaper Publication
16-Feb-2026 | Source : BSENewspaper Advertisement- Financial Results
Corporate Actions 
No Upcoming Board Meetings
Smruthi Organics Ltd has declared 15% dividend, ex-date: 13 Jun 25
No Splits history available
Smruthi Organics Ltd has announced 2:1 bonus issue, ex-date: 16 Mar 21
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Eaga Purushotham Malaiah (41.23%)
0 (1.21%)
28.83%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -29.46% vs 66.40% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -32.04% vs 287.27% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -10.71% vs -12.16% in Sep 2024
Growth in half year ended Sep 2025 is 740.00% vs -103.44% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -17.10% vs -0.08% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 77.44% vs -35.75% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -1.28% vs -9.50% in Mar 2024
YoY Growth in year ended Mar 2025 is -0.84% vs -13.08% in Mar 2024






